Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens

José Alejandro Pérez-Fidalgo, Susana Roselló, Elisa García-Garré, Esther Jordá, Paloma Martín-Martorell, Begoña Bermejo, Isabel Chirivella, Cecilia Guzman, Ana Lluch

Open source

DOI
10.1007/s10549-009-0426-x
Published
2009-07-03
Container
Breast Cancer Research and Treatment
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10549-009-0426-x,
  title = {Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens},
  author = {José Alejandro Pérez-Fidalgo and Susana Roselló and Elisa García-Garré and Esther Jordá and Paloma Martín-Martorell and Begoña Bermejo and Isabel Chirivella and Cecilia Guzman and Ana Lluch},
  year = {2009},
  journal = {Breast Cancer Research and Treatment},
  doi = {10.1007/s10549-009-0426-x},
  url = {https://doi.org/10.1007/s10549-009-0426-x}
}

RIS

TY  - JOUR
TI  - Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens
AU  - José Alejandro Pérez-Fidalgo
AU  - Susana Roselló
AU  - Elisa García-Garré
AU  - Esther Jordá
AU  - Paloma Martín-Martorell
AU  - Begoña Bermejo
AU  - Isabel Chirivella
AU  - Cecilia Guzman
AU  - Ana Lluch
PY  - 2009
JO  - Breast Cancer Research and Treatment
DO  - 10.1007/s10549-009-0426-x
UR  - https://doi.org/10.1007/s10549-009-0426-x
ER  - 

APA

Pérez-Fidalgo, J. A., Roselló, S., García-Garré, E., Jordá, E., Martín-Martorell, P., Bermejo, B., Chirivella, I., Guzman, C., & Lluch, A. (2009). Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-009-0426-x

Source records